Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,519 | 84 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Vision LLC | $1,548 | 18 | $0 (2023) |
| Genentech USA, Inc. | $601.23 | 27 | $0 (2024) |
| ABBVIE INC. | $396.82 | 9 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $342.59 | 6 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $316.40 | 8 | $0 (2024) |
| Johnson & Johnson Surgical Vision, Inc. | $237.93 | 5 | $0 (2021) |
| Alexion Pharmaceuticals, Inc. | $174.97 | 2 | $0 (2020) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $165.28 | 1 | $0 (2018) |
| Genentech, Inc. | $150.31 | 1 | $0 (2022) |
| Allergan, Inc. | $139.05 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $828.71 | 30 | Regeneron Healthcare Solutions, Inc. ($342.59) |
| 2023 | $1,109 | 25 | Alcon Vision LLC ($379.18) |
| 2022 | $852.69 | 7 | Alcon Vision LLC ($372.49) |
| 2021 | $1,099 | 15 | Alcon Vision LLC ($697.20) |
| 2020 | $247.99 | 4 | Alcon Vision LLC ($99.54) |
| 2019 | $125.00 | 1 | Alexion Pharmaceuticals, Inc. ($125.00) |
| 2018 | $257.76 | 2 | Bausch & Lomb, a division of Bausch Health US, LLC ($165.28) |
All Payment Transactions
84 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $107.10 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/27/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: Ophthalmology | ||||||
| 10/22/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/18/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/18/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $2.43 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/18/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $0.79 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/18/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $0.25 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/28/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $108.80 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/13/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $27.65 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/02/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/02/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $2.28 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/17/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $32.01 | General |
| Category: Ophthalmology | ||||||
| 07/12/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $32.03 | General |
| Category: EYE CARE | ||||||
| 06/28/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/28/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $0.73 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/21/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $28.27 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/10/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/10/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $1.89 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/03/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: EYE CARE | ||||||
| 04/17/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $31.43 | General |
| Category: Ophthalmology | ||||||
| 04/02/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $26.78 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/02/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $1.19 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/02/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $1.06 | General |
| Category: Immunology and Ophthalmology | ||||||
| 03/29/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/12/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 3,501 | 28,467 | $3.7M | $2.5M |
| 2022 | 11 | 466 | 558 | $190,416 | $41,665 |
| 2021 | 6 | 142 | 150 | $118,922 | $9,991 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 303 | 1,804 | $1.7M | $1.2M | 72.8% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 104 | 20,160 | $766,320 | $580,348 | 75.7% |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | Office | 2023 | 58 | 1,425 | $237,975 | $171,514 | 72.1% |
| 67028 | Injection of drug into eye | Office | 2023 | 451 | 1,203 | $183,840 | $121,518 | 66.1% |
| J3490 | Unclassified drugs | Office | 2023 | 33 | 40 | $110,000 | $70,739 | 64.3% |
| 92134 | Imaging of retina | Office | 2023 | 929 | 1,955 | $89,575 | $64,204 | 71.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 434 | 525 | $75,751 | $54,575 | 72.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 189 | 189 | $36,042 | $24,870 | 69.0% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 213 | 216 | $32,194 | $22,182 | 68.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 219 | 264 | $27,359 | $19,644 | 71.8% |
| 67041 | Removal of membrane of retina | Facility | 2023 | 43 | 43 | $110,191 | $17,712 | 16.1% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 12 | 100 | $34,800 | $17,418 | 50.1% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2023 | 31 | 31 | $85,171 | $14,540 | 17.1% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 110 | 110 | $19,114 | $13,261 | 69.4% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 96 | 98 | $15,260 | $10,980 | 72.0% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 22 | 22 | $57,295 | $10,317 | 18.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 88 | 92 | $10,442 | $7,183 | 68.8% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2023 | 26 | 26 | $57,898 | $6,465 | 11.2% |
| 67113 | Complex repair of detached retina and drainage of eye fluid between lens and retina | Facility | 2023 | 11 | 11 | $37,336 | $4,786 | 12.8% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2023 | 13 | 16 | $6,080 | $4,433 | 72.9% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 31 | 38 | $2,464 | $1,518 | 61.6% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 50 | 63 | $1,737 | $1,265 | 72.8% |
| 92250 | Photography of the retina | Office | 2023 | 18 | 18 | $756.00 | $541.99 | 71.7% |
| 92133 | Imaging of optic nerve | Office | 2023 | 17 | 18 | $981.00 | $413.98 | 42.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 50 | 66 | $12,210 | $5,798 | 47.5% |
About Dr. Travis Peck, MD
Dr. Travis Peck, MD is a Ophthalmology healthcare provider based in Salisbury, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/26/2017. The National Provider Identifier (NPI) number assigned to this provider is 1982132502.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Travis Peck, MD has received a total of $4,519 in payments from pharmaceutical and medical device companies, with $828.71 received in 2024. These payments were reported across 84 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($4,519).
As a Medicare-enrolled provider, Peck has provided services to 4,109 Medicare beneficiaries, totaling 29,175 services with total Medicare billing of $2.5M. Data is available for 3 years (2021–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Salisbury, MD
- Active Since 05/26/2017
- Last Updated 12/19/2022
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1982132502
Products in Payments
- OZURDEX (Drug) $535.87
- Constellation (Device) $478.40
- NGENUITY (Device) $474.77
- Vabysmo (Drug) $473.17
- EYLEA HD (Biological) $315.73
- AcrySof IQ VIVITY IOL (Device) $284.66
- Syfovre (Drug) $231.02
- AcrySof IQ PanOptix (Device) $227.48
- SUSVIMO (Drug) $150.31
- VABYSMO (Drug) $128.06
- iStent inject W (Device) $122.80
- Tecnis IOL (Device) $114.13
- Stellaris (Device) $103.74
- YUTIQ (Drug) $95.76
- AcrySof (Device) $83.10
- Tecnis iTec Preloaded Delivery System (Device) $77.43
- Izervay (Drug) $31.43
- EYLEA (Biological) $26.86
- Tecnis Simplicity (Device) $25.32
- Catalys Laser System (Device) $21.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Salisbury
Dr. Jeffrey Benner, M.d, M.D
Ophthalmology — Payments: $61,683
Donald Bergsma, M.d, M.D
Ophthalmology — Payments: $7,144
Dr. Jason Yonker, M.d, M.D
Ophthalmology — Payments: $5,369
John Butler, M.d, M.D
Ophthalmology — Payments: $4,182
Dr. Joseph Schwartz, M.d, M.D
Ophthalmology — Payments: $2,830
Paul Lagonigro, Md, MD
Ophthalmology — Payments: $2,283